TreeWAS – Variant ID: rs4478147

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T43.2 Other and unspecified antidepressants	0.000	0.924	0.076
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.927	0.073
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.930	0.070
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.931	0.069
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.932	0.068
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.932	0.068
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.932	0.068
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.933	0.067
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.934	0.066
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.939	0.061
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.941	0.058
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.942	0.058
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.942	0.058
H33.2 Serous retinal detachment	0.000	0.944	0.056
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.947	0.053
T43.9 Psychotropic drug, unspecified	0.000	0.947	0.053
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.947	0.053
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.948	0.052
T50.8 Diagnostic agents	0.000	0.948	0.052
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.949	0.051
T43.6 Psychostimulants with abuse potential	0.000	0.949	0.051
T50.4 Drugs affecting uric acid metabolism	0.000	0.950	0.050
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.950	0.050
T38.1 Thyroid hormones and substitutes	0.000	0.950	0.050
T38.9 Other and unspecified hormone antagonists	0.000	0.951	0.049
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.951	0.049
T38.7 Androgens and anabolic congeners	0.000	0.951	0.049
T38.5 Other oestrogens and progestogens	0.000	0.951	0.049
T38.4 Oral contraceptives	0.000	0.951	0.049
T38.2 Antithyroid drugs	0.000	0.951	0.049
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.951	0.049
T39.4 Antirheumatics, not elsewhere classified	0.000	0.951	0.049
T39.2 Pyrazolone derivatives	0.000	0.951	0.049
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.951	0.049
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.951	0.048
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.952	0.048
T50.7 Analeptics and opioid receptor antagonists	0.000	0.952	0.047
T50.5 Appetite depressants	0.000	0.952	0.047
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.952	0.047
T50.1 Loop [high-ceiling] diuretics	0.000	0.952	0.047
T50.0 Mineralocorticoids and their antagonists	0.000	0.952	0.047
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.953	0.047
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.953	0.047
G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified	0.046	0.954	0.000
T36 Poisoning by systemic antibiotics	0.000	0.954	0.046
T39.0 Salicylates	0.000	0.954	0.046
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.955	0.045
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.955	0.044
G04 Encephalitis, myelitis and encephalomyelitis	0.044	0.956	0.000
T45.5 Anticoagulants	0.000	0.956	0.044
H33.3 Retinal breaks without detachment	0.000	0.957	0.043
T38.0 Glucocorticoids and synthetic analogues	0.000	0.957	0.042
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.958	0.042
H33 Retinal detachments and breaks	0.000	0.959	0.041
T45.2 Vitamins, not elsewhere classified	0.000	0.959	0.041
G00-G09 Inflammatory diseases of the central nervous system	0.041	0.959	0.000
T45.0 Antiallergic and antiemetic drugs	0.000	0.961	0.039
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.962	0.038
T45.8 Other primarily systemic and haematological agents	0.000	0.962	0.038
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.962	0.038
T45.6 Fibrinolysis-affecting drugs	0.000	0.962	0.038
T45.4 Iron and its compounds	0.000	0.962	0.038
T45.3 Enzymes, not elsewhere classified	0.000	0.962	0.038
G04.8 Other encephalitis, myelitis and encephalomyelitis	0.038	0.962	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.962	0.038
G09 Sequelae of inflammatory diseases of central nervous system	0.038	0.962	0.000
T46.1 Calcium-channel blockers	0.000	0.963	0.037
T49.9 Topical agent, unspecified	0.000	0.963	0.037
T49.8 Other topical agents	0.000	0.963	0.037
T49.7 Dental drugs, topically applied	0.000	0.963	0.037
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.963	0.037
T49.5 Ophthalmological drugs and preparations	0.000	0.963	0.037
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.963	0.037
T49.3 Emollients, demulcents and protectants	0.000	0.963	0.037
T49.2 Local astringents and local detergents	0.000	0.963	0.037
T49.1 Antipruritics	0.000	0.963	0.037
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.963	0.037
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.963	0.037
G06 Intracranial and intraspinal abscess and granuloma	0.036	0.963	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.964	0.036
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.964	0.036
T46.7 Peripheral vasodilators	0.000	0.964	0.036
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.964	0.036
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.964	0.036
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.964	0.036
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.964	0.035
T48.4 Expectorants	0.000	0.964	0.035
T48.3 Antitussives	0.000	0.964	0.035
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.964	0.035
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.964	0.035
T48.0 Oxytocic drugs	0.000	0.964	0.035
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.964	0.035
G02 Meningitis in other infectious and parasitic diseases classified elsewhere	0.035	0.965	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.965	0.035
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.965	0.035
T47.7 Emetics	0.000	0.965	0.035
T47.6 Antidiarrhoeal drugs	0.000	0.965	0.035
T47.5 Digestants	0.000	0.965	0.035
T47.3 Saline and osmotic laxatives	0.000	0.965	0.035
T47.0 Histamine H(2)-receptor antagonists	0.000	0.965	0.035
T48.5 Anti-common-cold drugs	0.000	0.965	0.035
G03 Meningitis due to other and unspecified causes	0.035	0.965	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.965	0.035
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.965	0.035
T47.2 Stimulant laxatives	0.000	0.965	0.035
T36.0 Penicillins	0.000	0.966	0.034
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.967	0.033
T47.4 Other laxatives	0.000	0.967	0.033
T36.9 Systemic antibiotic, unspecified	0.000	0.967	0.033
T36.7 Antifungal antibiotics, systemically used	0.000	0.967	0.033
T36.6 Rifamycins	0.000	0.967	0.033
T36.5 Aminoglycosides	0.000	0.967	0.033
T36.2 Chloramphenicol group	0.000	0.967	0.033
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.967	0.033
G04.0 Acute disseminated encephalitis	0.033	0.967	0.000
H33.4 Traction detachment of retina	0.000	0.967	0.033
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.968	0.032
T37.5 Antiviral drugs	0.000	0.968	0.032
T37.4 Anthelminthics	0.000	0.968	0.032
T37.3 Other antiprotozoal drugs	0.000	0.968	0.032
T37.1 Antimycobacterial drugs	0.000	0.968	0.032
T37.0 Sulphonamides	0.000	0.968	0.032
T41.5 Therapeutic gases	0.000	0.968	0.032
T41.4 Anaesthetic, unspecified	0.000	0.968	0.032
T41.3 Local anaesthetics	0.000	0.968	0.032
T41.1 Intravenous anaesthetics	0.000	0.968	0.032
T41.0 Inhaled anaesthetics	0.000	0.968	0.032
G04.2 Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified	0.032	0.968	0.000
G04.1 Tropical spastic paraplegia	0.032	0.968	0.000
T36.8 Other systemic antibiotics	0.000	0.968	0.031
T36.4 Tetracyclines	0.000	0.968	0.031
T36.3 Macrolides	0.000	0.969	0.031
G08 Intracranial and intraspinal phlebitis and thrombophlebitis	0.031	0.969	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.969	0.031
G02.0 Meningitis in viral diseases classified elsewhere	0.031	0.969	0.000
G01 Meningitis in bacterial diseases classified elsewhere	0.031	0.969	0.000
G06.0 Intracranial abscess and granuloma	0.031	0.969	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.969	0.031
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.969	0.030
G03.9 Meningitis, unspecified	0.030	0.970	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.970	0.030
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.970	0.030
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.970	0.030
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.970	0.030
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.970	0.030
T44.0 Anticholinesterase agents	0.000	0.970	0.030
G06.1 Intraspinal abscess and granuloma	0.030	0.970	0.000
G07 Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere	0.030	0.970	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.971	0.029
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.971	0.029
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.971	0.028
G05 Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere	0.028	0.972	0.000
H33.1 Retinoschisis and retinal cysts	0.000	0.972	0.028
G06.2 Extradural and subdural abscess, unspecified	0.027	0.973	0.000
T41.2 Other and unspecified general anaesthetics	0.000	0.973	0.026
T40.5 Cocaine	0.000	0.973	0.026
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.974	0.025
G02.8 Meningitis in other specified infectious and parasitic diseases classified elsewhere	0.025	0.974	0.000
G02.1 Meningitis in mycoses	0.025	0.974	0.000
G03.8 Meningitis due to other specified causes	0.025	0.975	0.000
G03.2 Benign recurrent meningitis [Mollaret]	0.025	0.975	0.000
G03.1 Chronic meningitis	0.025	0.975	0.000
G03.0 Nonpyogenic meningitis	0.025	0.975	0.000
T40.1 Heroin	0.000	0.975	0.025
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.976	0.024
T40.8 Lysergide [LSD]	0.000	0.976	0.024
T40.7 Cannabis (derivatives)	0.000	0.976	0.024
T40.0 Opium	0.000	0.976	0.024
T40.2 Other opioids	0.000	0.976	0.024
T39.1 4-Aminophenol derivatives	0.000	0.976	0.024
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.977	0.023
T42.3 Barbiturates	0.000	0.977	0.022
G00 Bacterial meningitis, not elsewhere classified	0.022	0.978	0.000
T40.3 Methadone	0.000	0.978	0.022
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.979	0.021
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.979	0.021
T42.2 Succinimides and oxazolidinediones	0.000	0.979	0.021
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.979	0.021
T40.4 Other synthetic narcotics	0.000	0.979	0.021
H33.0 Retinal detachment with retinal break	0.000	0.979	0.021
T42.0 Hydantoin derivatives	0.000	0.980	0.020
G05.8 Encephalitis, myelitis and encephalomyelitis in other diseases classified elsewhere	0.020	0.980	0.000
G05.2 Encephalitis, myelitis and encephalomyelitis in other infectious and parasitic diseases classified elsewhere	0.020	0.980	0.000
G05.0 Encephalitis, myelitis and encephalomyelitis in bacterial diseases classified elsewhere	0.020	0.980	0.000
G05.1 Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere	0.018	0.981	0.000
T42.1 Iminostilbenes	0.000	0.982	0.018
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.982	0.018
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.984	0.016
G00.8 Other bacterial meningitis	0.016	0.984	0.000
G00.3 Staphylococcal meningitis	0.016	0.984	0.000
G00.2 Streptococcal meningitis	0.016	0.984	0.000
G00.0 Haemophilus meningitis	0.016	0.984	0.000
H33.5 Other retinal detachments	0.000	0.985	0.015
G00.1 Pneumococcal meningitis	0.014	0.986	0.000
D05.1 Intraductal carcinoma in situ	0.000	0.987	0.013
G00.9 Bacterial meningitis, unspecified	0.012	0.988	0.000
T40.6 Other and unspecified narcotics	0.001	0.988	0.011
I84.8 Unspecified haemorrhoids with other complications	0.011	0.989	0.000
D17.6 Benign lipomatous neoplasm of spermatic cord	0.000	0.989	0.011
I63.3 Cerebral infarction due to thrombosis of cerebral arteries	0.010	0.990	0.000
L60.0 Ingrowing nail	0.000	0.991	0.009
L89.9 Decubitus ulcer and pressure area, unspecified	0.000	0.992	0.008
K25.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.008	0.992	0.000
S02.20 Fracture of nasal bones (closed)	0.000	0.992	0.008
S02.2 Fracture of nasal bones	0.000	0.992	0.008
D05 Carcinoma in situ of breast	0.000	0.992	0.008
S02 Fracture of skull and facial bones	0.000	0.993	0.007
C18.9 Colon, unspecified	0.000	0.993	0.007
S02.9 Fracture of skull and facial bones, part unspecified	0.000	0.993	0.007
S02.90 Fracture of skull and facial bones, part unspecified (closed)	0.000	0.993	0.007
D05.7 Other carcinoma in situ of breast	0.000	0.993	0.007
G56.2 Lesion of ulnar nerve	0.007	0.993	0.000
S02.8 Fractures of other skull and facial bones	0.000	0.993	0.007
L89.2 Stage III decubitus ulcer	0.000	0.993	0.007
M77.12 Lateral epicondylitis (Upper arm)	0.000	0.993	0.007
S02.1 Fracture of base of skull	0.000	0.994	0.006
L89 Decubitus ulcer	0.000	0.994	0.006
B95.6 Staphylococcus aureus as the cause of diseases classified to other chapters	0.000	0.994	0.006
S02.7 Multiple fractures involving skull and facial bones	0.000	0.994	0.006
S02.21 Fracture of nasal bones (open)	0.000	0.994	0.006
S02.80 Fractures of other skull and facial bones (closed)	0.000	0.994	0.006
L89.3 Stage IV decubitus ulcer	0.000	0.994	0.006
Z85.3 Personal history of malignant neoplasm of breast	0.000	0.994	0.006
S02.6 Fracture of mandible	0.000	0.994	0.006
S02.10 Fracture of base of skull (closed)	0.000	0.994	0.006
S62.30 Fracture of other metacarpal bone (closed)	0.000	0.994	0.006
S02.0 Fracture of vault of skull	0.000	0.994	0.006
S02.70 Multiple fractures involving skull and facial bones (closed)	0.000	0.994	0.006
O36.8 Maternal care for other specified foetal problems	0.005	0.995	0.000
S02.3 Fracture of orbital floor	0.000	0.995	0.005
T42.4 Benzodiazepines	0.000	0.995	0.005
S02.91 Fracture of skull and facial bones, part unspecified (open)	0.000	0.995	0.005
S02.5 Fracture of tooth	0.000	0.995	0.005
S02.60 Fracture of mandible (closed)	0.000	0.995	0.005
S02.81 Fractures of other skull and facial bones (open)	0.000	0.995	0.005
L89.0 Stage I decubitus ulcer and pressure area	0.000	0.995	0.005
T78.3 Angioneurotic oedema	0.000	0.995	0.005
T78.2 Anaphylactic shock, unspecified	0.000	0.995	0.005
S02.71 Multiple fractures involving skull and facial bones (open)	0.000	0.995	0.005
D05.0 Lobular carcinoma in situ	0.000	0.995	0.005
S02.00 Fracture of vault of skull (closed)	0.000	0.995	0.005
T78 Adverse effects, not elsewhere classified	0.000	0.995	0.005
T78.0 Anaphylactic shock due to adverse food reaction	0.000	0.995	0.005
S02.11 Fracture of base of skull (open)	0.000	0.995	0.004
S02.61 Fracture of mandible (open)	0.000	0.995	0.004
S02.01 Fracture of vault of skull (open)	0.000	0.996	0.004
D02.0 Larynx	0.000	0.996	0.004
L60.9 Nail disorder, unspecified	0.000	0.996	0.004
D05.9 Carcinoma in situ of breast, unspecified	0.000	0.996	0.004
F43.1 Posttraumatic stress disorder	0.000	0.996	0.004
Z97.4 Presence of external hearing-aid	0.004	0.996	0.000
L60 Nail disorders	0.000	0.996	0.004
T78.1 Other adverse food reactions, not elsewhere classified	0.000	0.996	0.004
S02.31 Fracture of orbital floor (open)	0.000	0.996	0.004
F43.2 Adjustment disorders	0.000	0.996	0.004
S02.30 Fracture of orbital floor (closed)	0.000	0.996	0.004
D01 Carcinoma in situ of other and unspecified digestive organs	0.000	0.996	0.004
S02.51 Fracture of tooth (open)	0.000	0.996	0.004
D02 Carcinoma in situ of middle ear and respiratory system	0.000	0.996	0.004
D01.3 Anus and anal canal	0.000	0.996	0.004
S02.4 Fracture of malar and maxillary bones	0.000	0.996	0.004
D01.0 Colon	0.000	0.996	0.004
S02.50 Fracture of tooth (closed)	0.000	0.996	0.004
F42.9 Obsessive-compulsive disorder, unspecified	0.000	0.996	0.004
T78.9 Adverse effect, unspecified	0.000	0.996	0.004
D00-D09 In situ neoplasms	0.000	0.996	0.004
K65.0 Acute peritonitis	0.000	0.996	0.004
M84.03 Malunion of fracture (Forearm)	0.004	0.996	0.000
L60.3 Nail dystrophy	0.000	0.996	0.004
D17.3 Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites	0.004	0.996	0.000
A87.9 Viral meningitis, unspecified	0.004	0.996	0.000
M47.82 Other spondylosis (Cervical region)	0.000	0.996	0.004
F43 Reaction to severe stress, and adjustment disorders	0.000	0.996	0.004
L60.1 Onycholysis	0.000	0.997	0.003
D06.9 Cervix, unspecified	0.000	0.997	0.003
D06 Carcinoma in situ of cervix uteri	0.000	0.997	0.003
T78.8 Other adverse effects, not elsewhere classified	0.000	0.997	0.003
L60.5 Yellow nail syndrome	0.000	0.997	0.003
L60.4 Beau's lines	0.000	0.997	0.003
D04.7 Skin of lower limb, including hip	0.000	0.997	0.003
D01.2 Rectum	0.000	0.997	0.003
L90.5 Scar conditions and fibrosis of skin	0.000	0.997	0.003
S62.3 Fracture of other metacarpal bone	0.000	0.997	0.003
D01.9 Digestive organ, unspecified	0.000	0.997	0.003
D01.7 Other specified digestive organs	0.000	0.997	0.003
D01.5 Liver, gallbladder and bile ducts	0.000	0.997	0.003
D01.4 Other and unspecified parts of intestine	0.000	0.997	0.003
D01.1 Rectosigmoid junction	0.000	0.997	0.003
H50.0 Convergent concomitant strabismus	0.000	0.997	0.003
D02.4 Respiratory system, unspecified	0.000	0.997	0.003
D02.3 Other parts of respiratory system	0.000	0.997	0.003
D02.1 Trachea	0.000	0.997	0.003
Z92.4 Personal history of major surgery, not elsewhere classified	0.003	0.997	0.000
D02.2 Bronchus and lung	0.000	0.997	0.003
S62.31 Fracture of other metacarpal bone (open)	0.000	0.997	0.003
F43.8 Other reactions to severe stress	0.000	0.997	0.003
D04 Carcinoma in situ of skin	0.000	0.997	0.003
D06.1 Exocervix	0.000	0.997	0.003
D06.7 Other parts of cervix	0.000	0.997	0.003
N08.5 Glomerular disorders in systemic connective tissue disorders	0.003	0.997	0.000
Y44.2 Anticoagulants	0.003	0.997	0.000
H44.2 Degenerative myopia	0.000	0.997	0.003
D09 Carcinoma in situ of other and unspecified sites	0.000	0.997	0.003
S02.41 Fracture of malar and maxillary bones (open)	0.000	0.997	0.002
D04.6 Skin of upper limb, including shoulder	0.000	0.997	0.003
M84.0 Malunion of fracture	0.003	0.997	0.000
M77.1 Lateral epicondylitis	0.000	0.997	0.002
M84.07 Malunion of fracture (Ankle and foot)	0.002	0.997	0.000
M84.05 Malunion of fracture (Pelvic region and thigh)	0.002	0.998	0.000
K63.2 Fistula of intestine	0.000	0.998	0.002
F42 Obsessive-compulsive disorder	0.000	0.998	0.002
D06.0 Endocervix	0.000	0.998	0.002
M84.04 Malunion of fracture (Hand)	0.002	0.998	0.000
L60.8 Other nail disorders	0.000	0.998	0.002
L60.2 Onychogryphosis	0.000	0.998	0.002
D04.9 Skin, unspecified	0.000	0.998	0.002
D04.1 Skin of eyelid, including canthus	0.000	0.998	0.002
F43.0 Acute stress reaction	0.000	0.998	0.002
D04.8 Skin of other sites	0.000	0.998	0.002
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.000	0.998	0.002
S02.40 Fracture of malar and maxillary bones (closed)	0.000	0.998	0.002
T93.2 Sequelae of other fractures of lower limb	0.002	0.998	0.000
D09.1 Other and unspecified urinary organs	0.000	0.998	0.002
H74.8 Other specified disorders of middle ear and mastoid	0.000	0.998	0.002
D09.7 Carcinoma in situ of other specified sites	0.000	0.998	0.002
D09.3 Thyroid and other endocrine glands	0.000	0.998	0.002
D09.2 Eye	0.000	0.998	0.002
D09.9 Carcinoma in situ, unspecified	0.000	0.998	0.002
M84.09 Malunion of fracture (Site unspecified)	0.002	0.998	0.000
M84.00 Malunion of fracture (Multiple sites)	0.002	0.998	0.000
C48.2 Peritoneum, unspecified	0.002	0.998	0.000
D86.1 Sarcoidosis of lymph nodes	0.002	0.998	0.000
F43.9 Reaction to severe stress, unspecified	0.000	0.998	0.002
M84.01 Malunion of fracture (Shoulder region)	0.002	0.998	0.000
M75.4 Impingement syndrome of shoulder	0.000	0.998	0.002
M77.19 Lateral epicondylitis (Site unspecified)	0.000	0.998	0.002
M77.18 Lateral epicondylitis-Other	0.000	0.998	0.002
M77.17 Lateral epicondylitis-Ankle/Foot	0.000	0.998	0.002
M77.16 Lateral epicondylitis (Lower leg)	0.000	0.998	0.002
M77.15 Lateral epicondylitis (Pelvic region and thigh)	0.000	0.998	0.002
M77.14 Lateral epicondylitis-Hand	0.000	0.998	0.002
M77.11 Lateral epicondylitis-Shldr region	0.000	0.998	0.002
M77.10 Lateral epicondylitis (Multiple sites)	0.000	0.998	0.002
D04.0 Skin of lip	0.000	0.998	0.002
A87 Viral meningitis	0.002	0.998	0.000
F40-F48 Neurotic, stress-related and somatoform disorders	0.000	0.998	0.002
D86.8 Sarcoidosis of other and combined sites	0.002	0.998	0.000
M84.08 Malunion of fracture (Other)	0.002	0.998	0.000
M84.06 Malunion of fracture (Lower leg)	0.002	0.998	0.000
M88.90 Paget's disease of bone, unspecified (Multiple sites)	0.000	0.998	0.002
B37.3 Candidiasis of vulva and vagina	0.000	0.998	0.002
K65 Peritonitis	0.000	0.998	0.002
F42.8 Other obsessive-compulsive disorders	0.000	0.998	0.002
J86.9 Pyothorax without fistula	0.000	0.998	0.002
K65.9 Peritonitis, unspecified	0.000	0.998	0.002
C08.9 Major salivary gland, unspecified	0.002	0.998	0.000
D04.4 Skin of scalp and neck	0.000	0.998	0.002
O36.0 Maternal care for rhesus isoimmunisation	0.002	0.998	0.000
K35.8 Acute appendicitis, other and unspecified	0.000	0.998	0.002
A87.2 Lymphocytic choriomeningitis	0.002	0.998	0.000
D00.2 Stomach	0.000	0.998	0.002
M05.97 Seropositive rheumatoid arthritis, unspecified (Ankle and foot)	0.002	0.998	0.000
D04.5 Skin of trunk	0.000	0.998	0.002
C01 Malignant neoplasm of base of tongue	0.002	0.998	0.000
T78.4 Allergy, unspecified	0.000	0.998	0.002
M24.11 Other articular cartilage disorders (Shoulder region)	0.000	0.998	0.002
M77.13 Lateral epicondylitis-Forearm	0.000	0.998	0.002
F41.9 Anxiety disorder, unspecified	0.000	0.998	0.002
F42.1 Predominantly compulsive acts [obsessional rituals]	0.000	0.998	0.002
Z93.1 Gastrostomy status	0.002	0.998	0.000
D09.0 Bladder	0.000	0.998	0.002
X45.0 Home	0.000	0.998	0.002
F42.2 Mixed obsessional thoughts and acts	0.000	0.998	0.002
A87.8 Other viral meningitis	0.002	0.998	0.000
A87.1 Adenoviral meningitis	0.002	0.998	0.000
T66-T78 Other and unspecified effects of external causes	0.000	0.998	0.002
D00.1 Oesophagus	0.000	0.998	0.001
F40.8 Other phobic anxiety disorders	0.000	0.998	0.002
A87.0 Enteroviral meningitis	0.002	0.998	0.000
O36.9 Maternal care for foetal problem, unspecified	0.002	0.998	0.000
F44 Dissociative [conversion] disorders	0.000	0.998	0.002
F40 Phobic anxiety disorders	0.000	0.998	0.002
F45.3 Somatoform autonomic dysfunction	0.000	0.998	0.002
F48 Other neurotic disorders	0.000	0.998	0.002
M84.02 Malunion of fracture (Upper arm)	0.001	0.998	0.000
D04.2 Skin of ear and external auricular canal	0.000	0.998	0.001
F44.9 Dissociative [conversion] disorder, unspecified	0.000	0.998	0.002
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.000	0.998	0.002
M23.61 Other spontaneous disruption of ligament(s) of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.002	0.998	0.000
G56.0 Carpal tunnel syndrome	0.000	0.998	0.002
K40.3 Unilateral or unspecified inguinal hernia, with obstruction, without gangrene	0.000	0.998	0.002
K51.3 Ulcerative (chronic) rectosigmoiditis	0.002	0.998	0.000
N30.2 Other chronic cystitis	0.002	0.998	0.000
L90 Atrophic disorders of skin	0.000	0.998	0.002
F42.0 Predominantly obsessional thoughts or ruminations	0.000	0.998	0.001
F45.4 Persistent somatoform pain disorder	0.000	0.998	0.002
K56.5 Intestinal adhesions [bands] with obstruction	0.000	0.998	0.002
F45 Somatoform disorders	0.000	0.998	0.002
T66 Unspecified effects of radiation	0.000	0.998	0.002
O14.0 Moderate preeclampsia	0.002	0.998	0.000
O36 Maternal care for other known or suspected foetal problems	0.002	0.998	0.000
K51.8 Other ulcerative colitis	0.002	0.998	0.000
C08 Malignant neoplasm of other and unspecified major salivary glands	0.002	0.998	0.000
D32.9 Meninges, unspecified	0.000	0.998	0.002
F51.3 Sleepwalking [somnambulism]	0.002	0.998	0.000
M05.9 Seropositive rheumatoid arthritis, unspecified	0.002	0.998	0.000
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)	0.002	0.998	0.000
D04.3 Skin of other and unspecified parts of face	0.000	0.998	0.002
H83.0 Labyrinthitis	0.000	0.998	0.002
J95.0 Tracheostomy malfunction	0.000	0.998	0.002
M14.6 Neuropathic arthropathy	0.000	0.998	0.002
M22.8 Other disorders of patella	0.002	0.998	0.000
A49.1 Streptococcal infection, unspecified	0.000	0.998	0.002
F40.0 Agoraphobia	0.000	0.998	0.001
F44.5 Dissociative convulsions	0.000	0.998	0.001
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.002	0.998	0.000
T74 Maltreatment syndromes	0.000	0.998	0.001
T69 Other effects of reduced temperature	0.000	0.998	0.001
T67 Effects of heat and light	0.000	0.998	0.001
D00.0 Lip, oral cavity and pharynx	0.001	0.998	0.001
L90.8 Other atrophic disorders of skin	0.000	0.998	0.001
T73 Effects of other deprivation	0.000	0.998	0.001
F40.1 Social phobias	0.000	0.998	0.001
F44.8 Other dissociative [conversion] disorders	0.000	0.998	0.001
F44.7 Mixed dissociative [conversion] disorders	0.000	0.998	0.001
F44.6 Dissociative anaesthesia and sensory loss	0.000	0.998	0.001
F44.3 Trance and possession disorders	0.000	0.998	0.001
F44.2 Dissociative stupor	0.000	0.998	0.001
F44.1 Dissociative fugue	0.000	0.998	0.001
L89.1 Stage II decubitus ulcer	0.000	0.998	0.001
T70 Effects of air pressure and water pressure	0.000	0.998	0.001
D86.3 Sarcoidosis of skin	0.001	0.998	0.000
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere	0.000	0.998	0.002
Q54.0 Hypospadias, balanic	0.000	0.998	0.001
Y00.9 Unspecified place	0.001	0.998	0.000
B99 Other and unspecified infectious diseases	0.000	0.998	0.001
F45.9 Somatoform disorder, unspecified	0.000	0.998	0.001
F48.8 Other specified neurotic disorders	0.000	0.998	0.001
F48.1 Depersonalisation-derealisation syndrome	0.000	0.998	0.001
K85.9 Acute pancreatitis, unspecified	0.001	0.998	0.000
M05.93 Seropositive rheumatoid arthritis, unspecified (Forearm)	0.001	0.999	0.000
M05.91 Seropositive rheumatoid arthritis, unspecified (Shoulder region)	0.001	0.999	0.000
M88.99 Paget's disease of bone, unspecified (Site unspecified)	0.000	0.999	0.001
F48.0 Neurasthenia	0.000	0.999	0.001
M65.43 Radial styloid tenosynovitis [de Quervain] (Forearm)	0.000	0.999	0.001
C08.0 Submandibular gland	0.001	0.999	0.000
F45.1 Undifferentiated somatoform disorder	0.000	0.999	0.001
L90.6 Striae atrophicae	0.000	0.999	0.001
L90.4 Acrodermatitis chronica atrophicans	0.000	0.999	0.001
L90.3 Atrophoderma of Pasini and Pierini	0.000	0.999	0.001
L90.2 Anetoderma of Jadassohn-Pellizzari	0.000	0.999	0.001
L90.1 Anetoderma of Schweninger-Buzzi	0.000	0.999	0.001
O36.7 Maternal care for viable foetus in abdominal pregnancy	0.001	0.999	0.000
M05.94 Seropositive rheumatoid arthritis, unspecified (Hand)	0.001	0.999	0.000
F40.9 Phobic anxiety disorder, unspecified	0.000	0.999	0.001
F44.0 Dissociative amnesia	0.000	0.999	0.001
J95.8 Other postprocedural respiratory disorders	0.000	0.999	0.001
L90.9 Atrophic disorder of skin, unspecified	0.000	0.999	0.001
M34.9 Systemic sclerosis, unspecified	0.000	0.999	0.001
O36.2 Maternal care for hydrops foetalis	0.001	0.999	0.000
T71 Asphyxiation	0.000	0.999	0.001
M24.15 Other articular cartilage disorders (Pelvic region and thigh)	0.000	0.999	0.001
C08.8 Overlapping lesion of major salivary glands	0.001	0.999	0.000
C08.1 Sublingual gland	0.001	0.999	0.000
C48.0 Retroperitoneum	0.001	0.999	0.000
T68 Hypothermia	0.000	0.999	0.001
M05.98 Seropositive rheumatoid arthritis, unspecified (Other)	0.001	0.999	0.000
F45.2 Hypochondriacal disorder	0.000	0.999	0.001
H50.2 Vertical strabismus	0.000	0.999	0.001
L90.0 Lichen sclerosus et atrophicus	0.000	0.999	0.001
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)	0.001	0.999	0.000
C48.1 Specified parts of peritoneum	0.001	0.999	0.000
D63.8 Anaemia in other chronic diseases classified elsewhere	0.000	0.999	0.001
F48.9 Neurotic disorder, unspecified	0.000	0.999	0.001
S12.70 Multiple fractures of cervical spine (closed)	0.001	0.999	0.000
B95.1 Streptococcus, group B, as the cause of diseases classified to other chapters	0.000	0.999	0.001
C48.8 Overlapping lesion of retroperitoneum and peritoneum	0.001	0.999	0.000
F45.0 Somatisation disorder	0.000	0.999	0.001
G99.0 Autonomic neuropathy in endocrine and metabolic diseases	0.000	0.999	0.001
T67.9 Effects of heat and light, unspecified	0.000	0.999	0.001
T67.8 Other effects of heat and light	0.000	0.999	0.001
T67.7 Heat oedema	0.000	0.999	0.001
T67.6 Heat fatigue, transient	0.000	0.999	0.001
T67.5 Heat exhaustion, unspecified	0.000	0.999	0.001
T67.4 Heat exhaustion due to salt depletion	0.000	0.999	0.001
T67.3 Heat exhaustion, anhydrotic	0.000	0.999	0.001
T67.2 Heat cramp	0.000	0.999	0.001
T67.1 Heat syncope	0.000	0.999	0.001
T67.0 Heatstroke and sunstroke	0.000	0.999	0.001
T69.9 Effect of reduced temperature, unspecified	0.000	0.999	0.001
T69.8 Other specified effects of reduced temperature	0.000	0.999	0.001
T69.1 Chilblains	0.000	0.999	0.001
T69.0 Immersion hand and foot	0.000	0.999	0.001
T74.9 Maltreatment syndrome, unspecified	0.000	0.999	0.001
T74.8 Other maltreatment syndromes	0.000	0.999	0.001
T74.3 Psychological abuse	0.000	0.999	0.001
T74.2 Sexual abuse	0.000	0.999	0.001
T74.1 Physical abuse	0.000	0.999	0.001
T74.0 Neglect or abandonment	0.000	0.999	0.001
D86 Sarcoidosis	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations